alanine has been researched along with Pemphigoid, Benign Mucous Membrane in 1 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Pemphigoid, Benign Mucous Membrane: A chronic blistering disease with predilection for mucous membranes and less frequently the skin, and with a tendency to scarring. It is sometimes called ocular pemphigoid because of conjunctival mucous membrane involvement.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Long-term treatment with topical rebamipide and diquafosol can improve dry eye in patients with cGVHD or OCP-like disease." | 7.81 | Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. ( Fukui, M; Kamoi, M; Kawakita, T; Mukai, S; Ogawa, Y; Saijo-Ban, Y; Simmura, S; Tsubota, K; Yaguchi, S; Yamane, M, 2015) |
| "Long-term treatment with topical rebamipide and diquafosol can improve dry eye in patients with cGVHD or OCP-like disease." | 3.81 | Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. ( Fukui, M; Kamoi, M; Kawakita, T; Mukai, S; Ogawa, Y; Saijo-Ban, Y; Simmura, S; Tsubota, K; Yaguchi, S; Yamane, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamane, M | 1 |
| Ogawa, Y | 1 |
| Fukui, M | 1 |
| Kamoi, M | 1 |
| Saijo-Ban, Y | 1 |
| Yaguchi, S | 1 |
| Mukai, S | 1 |
| Kawakita, T | 1 |
| Simmura, S | 1 |
| Tsubota, K | 1 |
1 other study available for alanine and Pemphigoid, Benign Mucous Membrane
| Article | Year |
|---|---|
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Topics: Administration, Topical; Aged; Alanine; Drug Therapy, Combination; Dry Eye Syndromes; Enzyme Inhibit | 2015 |